• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CAMP4 Therapeutics Corporation - Common Stock (NQ:CAMP)

    3.040 +0.040 (+1.33%)
    Streaming Delayed Price Updated: 3:12 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 116,473
    Open 3.040
    Bid (Size) 2.990 (8)
    Ask (Size) 3.040 (1)
    Prev. Close 3.000
    Today's Range 2.810 - 3.080
    52wk Range 1.305 - 12.30
    Shares Outstanding 20,161,073
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Wednesday's After-Market Session
     
    Via Benzinga
    Wednesday's after hours session: top gainers and losers
    As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
    Via Chartmill

    Performance

    YTD
    -38.3%
    -38.3%
    1 Month
    +98.7%
    +98.7%
    3 Month
    +104.0%
    +104.0%
    6 Month
    -31.2%
    -31.2%
    1 Year
    -71.6%
    -71.6%

    More News

    Read More
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
    From CAMP4 Therapeutics
    Via GlobeNewswire
    Camp4 Reports Q2 Revenue Beats Estimates
    Via The Motley Fool
    CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
    From CAMP4 Therapeutics
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Sequans Appoints Jason W. Cohenour to Board of Directors
    Via Newsfile
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    This Sandisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
    Via Benzinga
    CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American
    From CAMP4 Therapeutics
    Via GlobeNewswire
    CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
    From CAMP4 Therapeutics
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
    From CAMP4 Therapeutics
    Via GlobeNewswire
    Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2
    Via Benzinga
    CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
    From CAMP4 Therapeutics
    Via GlobeNewswire
    CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
    From CAMP4 Therapeutics
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    CAMP4 to Participate in Upcoming Investor Conferences
    From CAMP4 Therapeutics
    Via GlobeNewswire
    CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
    From CAMP4 Therapeutics
    Via GlobeNewswire
    CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones
    From CAMP4 Therapeutics
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga

    Frequently Asked Questions

    Is CAMP4 Therapeutics Corporation - Common Stock publicly traded?
    Yes, CAMP4 Therapeutics Corporation - Common Stock is publicly traded.
    What exchange does CAMP4 Therapeutics Corporation - Common Stock trade on?
    CAMP4 Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CAMP4 Therapeutics Corporation - Common Stock?
    The ticker symbol for CAMP4 Therapeutics Corporation - Common Stock is CAMP on the Nasdaq Stock Market
    What is the current price of CAMP4 Therapeutics Corporation - Common Stock?
    The current price of CAMP4 Therapeutics Corporation - Common Stock is 3.040
    When was CAMP4 Therapeutics Corporation - Common Stock last traded?
    The last trade of CAMP4 Therapeutics Corporation - Common Stock was at 09/26/25 03:12 PM ET
    What is the market capitalization of CAMP4 Therapeutics Corporation - Common Stock?
    The market capitalization of CAMP4 Therapeutics Corporation - Common Stock is 61.29M
    How many shares of CAMP4 Therapeutics Corporation - Common Stock are outstanding?
    CAMP4 Therapeutics Corporation - Common Stock has 61M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.